NASDAQ : NGEN
NervGen Pharma Corp. — Financial statements
Other · Canada
Last price 1.37 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 147.31M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in CAD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 11.78M | 11.17M | 9.37M | 9.73M | 6.41M | 5.94M |
| Research & Development | 20.81M | 13.91M | 15.81M | 8.05M | 16.61M | 6.87M |
| Operating Expenses | 32.59M | 25.08M | 25.18M | 17.78M | 23.03M | 12.81M |
| Operating Income | -32.59M | -25.08M | -25.18M | -17.78M | -23.03M | -12.81M |
| Interest Expense | -514.60K | |||||
| Interest & Investment Income | 423.27K | 333.42K | 812.62K | 550.07K | 201.40K | 29.42K |
| Currency Exchange Gain (Loss) | 1.81M | -409.41K | 249.44K | -161.04K | 706.73K | 55.23K |
| Other Non Operating Income (Expenses) | 8.12M | -18.96M | -135.96K | -4.99M | 1.91M | |
| Pretax Income | -22.24M | -44.12M | -24.25M | -22.38M | -20.72M | -12.73M |
| Net Income | -22.24M | -44.12M | -24.25M | -22.38M | -20.72M | -12.73M |
| Net Income to Common | -22.24M | -44.12M | -24.25M | -22.38M | -20.72M | -12.73M |
| Shares Outstanding (Basic) | 79.90M | 72.33M | 67.32M | 59.29M | 52.65M | 39.29M |
| Shares Outstanding (Diluted) | 79.90M | 72.33M | 67.32M | 59.29M | 52.65M | 39.29M |
| EPS (Basic) | -0.28 | -0.61 | -0.36 | -0.38 | -0.39 | -0.32 |
| EPS (Diluted) | -0.65 | -0.61 | -0.36 | -0.38 | -0.39 | -0.32 |
| Free Cash Flow | -25.65M | -19.50M | -16.84M | -11.30M | -17.81M | -8.27M |
| Free Cash Flow Per Share | -0.32 | -0.27 | -0.25 | -0.19 | -0.34 | -0.21 |
| EBITDA | -32.54M | -25.02M | -25.11M | -17.72M | -22.91M | -12.77M |
| D&A For EBITDA | 55.80K | 55.80K | 61.31K | 55.04K | 115.11K | 42.63K |
| EBIT | -32.59M | -25.08M | -25.18M | -17.78M | -23.03M | -12.81M |
Balance sheet
Fiscal year January - December; amounts in CAD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 86.79M | 22.07M | 17.27M | 11.66M | 22.45M | 16.93M |
| Cash & Short-Term Investments | 86.79M | 22.07M | 17.27M | 11.66M | 22.45M | 16.93M |
| Accounts Receivable | 8.37K | 97.23K | ||||
| Other Receivables | 200.24K | 80.83K | 415.30K | 250.21K | 27.03K | 64.00K |
| Receivables | 200.24K | 89.19K | 512.53K | 250.21K | 27.03K | 64.00K |
| Prepaid Expenses | 2.59M | 393.59K | 290.06K | 106.66K | 79.64K | 65.01K |
| Other Current Assets | 227.95K | 248.06K | 942.82K | 499.07K | 590.27K | 362.57K |
| Total Current Assets | 89.81M | 22.80M | 19.01M | 12.52M | 23.15M | 17.42M |
| Property, Plant & Equipment | 199.78K | 295.28K | 2.69K | |||
| Other Intangible Assets | 381.26K | 409.16K | 464.96K | 520.75K | 431.40K | 473.15K |
| Long-Term Accounts Receivable | 8.37K | |||||
| Total Assets | 90.19M | 23.21M | 19.49M | 13.24M | 23.88M | 17.90M |
| Accounts Payable | 29.48K | 27.46K | 33.44K | 3.32M | 2.00M | 352.55K |
| Accrued Expenses | 4.26M | 4.63M | 4.91M | 1.40M | 725.53K | |
| Current Portion of Leases | 8.37K | 97.23K | 91.59K | 86.27K | ||
| Other Current Liabilities | 39.06M | 15.07M | 11.86M | 11.73M | 6.73M | |
| Total Current Liabilities | 43.35M | 19.73M | 16.90M | 15.14M | 10.22M | 1.08M |
| Long-Term Leases | 8.37K | 105.60K | 197.19K | |||
| Total Liabilities | 43.35M | 19.73M | 16.91M | 15.25M | 10.41M | 1.08M |
| Common Stock | 140.55M | 103.00M | 81.19M | 58.93M | 57.41M | 42.40M |
| Retained Earnings | -133.29M | -146.76M | -102.65M | -78.15M | -55.77M | -35.05M |
| Comprehensive Income & Other | 39.58M | 47.24M | 24.03M | 17.21M | 11.82M | 9.46M |
| Shareholders' Equity | 46.84M | 3.48M | 2.58M | -2.01M | 13.46M | 16.82M |
| Total Liabilities & Equity | 90.19M | 23.21M | 19.49M | 13.24M | 23.88M | 17.90M |
| Total Debt | 8.37K | 105.60K | 197.19K | 283.45K | ||
| Net Cash (Debt) | 86.79M | 22.06M | 17.16M | 11.46M | 22.17M | 16.93M |
| Net Cash Per Share | 1.09 | 0.30 | 0.25 | 0.19 | 0.42 | 0.43 |
| Filing Date Shares Outstanding | 107.52M | 80.93M | 70.99M | 69.93M | 59.13M | 46.23M |
| Total Common Shares Outstanding | 106.41M | 79.65M | 70.33M | 59.61M | 58.78M | 46.19M |
| Working Capital | 46.46M | 3.07M | 2.11M | -2.62M | 12.93M | 16.34M |
| Book Value Per Share | 0.44 | 0.04 | 0.04 | -0.03 | 0.23 | 0.36 |
| Tangible Book Value | 46.46M | 3.07M | 2.11M | -2.53M | 13.03M | 16.35M |
| Tangible Book Value Per Share | 0.44 | 0.04 | 0.03 | -0.04 | 0.22 | 0.35 |
Cash flow statement
Fiscal year January - December; amounts in CAD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -22.24M | -44.12M | -24.25M | -22.38M | -20.72M | -12.73M |
| Depreciation & Amortization | 55.80K | 55.80K | 83.80K | 145.00K | 115.11K | 42.63K |
| Loss (Gain) From Sale of Assets | 6.85K | |||||
| Stock-Based Compensation | 5.89M | 5.39M | 6.04M | 6.04M | 2.77M | 4.02M |
| Other Operating Activities | -6.21M | 18.51M | 440.09K | 5.14M | -2.07M | -31.38K |
| Change in Accounts Receivable | -103.28K | 334.48K | -165.09K | -223.18K | 36.98K | -1.41K |
| Change in Accounts Payable | -883.52K | -268.24K | 1.23M | -74.49K | 2.32M | 318.73K |
| Change in Other Net Operating Assets | -2.16M | 591.22K | -223.74K | 57.32K | -242.33K | 113.17K |
| Operating Cash Flow | -25.65M | -19.50M | -16.84M | -11.30M | -17.78M | -8.27M |
| Capital Expenditures | -5.62K | -21.11K | -2.75K | |||
| Sale of Property, Plant & Equipment | 2.55K | |||||
| Sale (Purchase) of Intangibles | -135.78K | -42.34K | ||||
| Other Investing Activities | 58.87K | 100.93K | 58.87K | |||
| Investing Cash Flow | 58.87K | 100.93K | 58.87K | -138.85K | -21.11K | -45.09K |
| Long-Term Debt Repaid | -100.93K | -100.93K | -100.93K | -75.69K | ||
| Lease Payments | -58.87K | -100.93K | -100.93K | -100.93K | -75.69K | |
| Net Debt Issued (Repaid) | -58.87K | -100.93K | -100.93K | -100.93K | -75.69K | |
| Issuance of Common Stock | 104.86M | 24.76M | 24.43M | 867.21K | 22.85M | 21.28M |
| Other Financing Activities | -6.14M | -892.78K | -1.63M | -129.04K | -1.67M | |
| Financing Cash Flow | 98.66M | 23.76M | 22.70M | 766.28K | 22.64M | 19.61M |
| Foreign Exchange Rate Adjustments | -1.96M | 436.49K | -305.01K | -123.89K | 686.58K | 31.38K |
| Net Cash Flow | 71.12M | 4.80M | 5.61M | -10.79M | 5.52M | 11.33M |
| Free Cash Flow | -25.65M | -19.50M | -16.84M | -11.30M | -17.81M | -8.27M |
| Free Cash Flow Per Share | -0.32 | -0.27 | -0.25 | -0.19 | -0.34 | -0.21 |
| Levered Free Cash Flow | 8.94M | -6.29M | -8.74M | -303.87K | -3.00M | -3.56M |
| Unlevered Free Cash Flow | 8.94M | -6.29M | -8.74M | -303.87K | -2.67M | -3.56M |
| Free Cash Flow After Leases | -25.71M | -19.60M | -16.94M | -11.40M | -17.88M | -8.27M |
| Change in Working Capital | -3.15M | 657.46K | 838.56K | -240.35K | 2.11M | 430.50K |
Ratios
Fiscal year January - December; amounts in CAD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 147.31M | 445.73M | 153.27M | 121.60M | 69.83M | 96.62M |
| Enterprise Value | 86.19M | 437.59M | 137.82M | 110.83M | 49.87M | 90.10M |
| Last Close Price | 1.37 | 5.60 | 2.18 | 2.04 | 1.19 | 2.13 |
| PB Ratio | 4.42 | 175.77 | 85.59 | -79.93 | 7.02 | 7.27 |
| P/TBV Ratio | 4.50 | 199.21 | 104.44 | 7.25 | 7.48 | |
| Debt / Equity Ratio | 0.00 | 0.04 | -0.10 | 0.02 | ||
| Net Debt / Equity Ratio | -1.85 | -6.34 | -6.66 | 5.71 | -1.65 | -1.01 |
| Net Debt / EBITDA Ratio | 2.67 | 0.88 | 0.68 | 0.65 | 0.97 | 1.33 |
| Net Debt / FCF Ratio | 3.38 | 1.13 | 1.02 | 1.01 | 1.25 | 2.05 |
| Quick Ratio | 2.01 | 1.12 | 1.05 | 0.79 | 2.20 | 15.76 |
| Current Ratio | 2.07 | 1.16 | 1.12 | 0.83 | 2.27 | 16.16 |
| Return on Equity (ROE) | -96.84% | -1,457.57% | -8,546.24% | -390.89% | -136.87% | -111.94% |
| Return on Assets (ROA) | -38.04% | -73.42% | -96.17% | -59.88% | -68.90% | -65.17% |
| Return on Capital Employed (ROCE) | -69.60% | -721.30% | -973.90% | 933.90% | -168.60% | -76.20% |
| Earnings Yield | -33.36% | -7.22% | -11.00% | -13.94% | -21.93% | -10.41% |
| FCF Yield | -12.46% | -3.19% | -7.64% | -7.04% | -18.84% | -6.77% |
| Buyback Yield / Dilution | -13.43% | -7.44% | -13.55% | -12.61% | -34.00% | -22.35% |